New research adds evidence to link between Thimerosal (a common vaccine preservative) and autism:<\/p>\n
In a study just published, a causal connection between Thimerosal, the preservative often used in vaccines, and the brain pathology found in patients diagnosed with autism spectrum disorder (ASD), has been established. The study,\u00a0A Mitochondrial Dysfunction, Impaired Oxidative-Reduction Activity, Degeneration, and Death in Human Neuronal and Fetal Cells Induced by Low-Level Exposure to Thimerosal and Other Metal Compounds<\/i>\u00a0was published in the June 2009 issue of the peer-reviewed journal\u00a0Toxicology & Environmental Toxicology.<\/i>1<\/sup><\/p>\n In the study, it was found that the amounts of Thimerosal found in inoculations commonly given to infants in the 1990s and still in use today (though more limited) induced levels of cellular toxicity. This cellular damage was consistent with that found in studies of patients diagnosed with ASD.<\/p>\n Both studies found significant mitochondrial dysfunction, reduced cellular oxidative-reduction activity, cell degeneration, and cell death being tied to ASD. All of these contribute significantly to ASD diagnosis and are also often attributed to other childhood and early development maladies.<\/p>\n